Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers

The specific modification of the outer surface of the promising porous metal-organic framework nanocarriers (nanoMOFs) preserving their characteristic porosity is still a major challenge. Here a simple, fast, and biofriendly method for the external functionalization of the benchmarked mesoporous iro...

Full description

Saved in:
Bibliographic Details
Published inAdvanced healthcare materials Vol. 4; no. 8; p. 1246
Main Authors Bellido, Elena, Hidalgo, Tania, Lozano, Maria Victoria, Guillevic, Mazheva, Simón-Vázquez, Rosana, Santander-Ortega, Manuel J, González-Fernández, África, Serre, Christian, Alonso, Maria J, Horcajada, Patricia
Format Journal Article
LanguageEnglish
Published Germany 03.06.2015
Subjects
Online AccessGet more information

Cover

Loading…
Abstract The specific modification of the outer surface of the promising porous metal-organic framework nanocarriers (nanoMOFs) preserving their characteristic porosity is still a major challenge. Here a simple, fast, and biofriendly method for the external functionalization of the benchmarked mesoporous iron(III) trimesate nanoparticles MIL-100(Fe) with heparin, a biopolymer associated with longer-blood circulation times is reported. First, the coated nanoparticles showed intact crystalline structure and porosity with improved colloidal stability under simulated physiological conditions, preserving in addition its encapsulation and controlled release capacities. The effect of the heparin coating on the nanoMOF interactions with the biological environment is evaluated through cell uptake, cytotoxicity, oxidative stress, cytokine production, complement activation, and protein adsorption analysis. These results confirmed that the heparin coating endowed the nanoMOFs with improved biological properties, such as reduced cell recognition, lack of complement activation, and reactive oxygen species production. Overall, the ability to coat the surface of the nanoMOFs using a simple and straight-forward approach could be taken as a way to enhance the versatility and, thus, the potential of porous MOF nanoparticles in biomedicine.
AbstractList The specific modification of the outer surface of the promising porous metal-organic framework nanocarriers (nanoMOFs) preserving their characteristic porosity is still a major challenge. Here a simple, fast, and biofriendly method for the external functionalization of the benchmarked mesoporous iron(III) trimesate nanoparticles MIL-100(Fe) with heparin, a biopolymer associated with longer-blood circulation times is reported. First, the coated nanoparticles showed intact crystalline structure and porosity with improved colloidal stability under simulated physiological conditions, preserving in addition its encapsulation and controlled release capacities. The effect of the heparin coating on the nanoMOF interactions with the biological environment is evaluated through cell uptake, cytotoxicity, oxidative stress, cytokine production, complement activation, and protein adsorption analysis. These results confirmed that the heparin coating endowed the nanoMOFs with improved biological properties, such as reduced cell recognition, lack of complement activation, and reactive oxygen species production. Overall, the ability to coat the surface of the nanoMOFs using a simple and straight-forward approach could be taken as a way to enhance the versatility and, thus, the potential of porous MOF nanoparticles in biomedicine.
Author Alonso, Maria J
González-Fernández, África
Lozano, Maria Victoria
Hidalgo, Tania
Horcajada, Patricia
Guillevic, Mazheva
Bellido, Elena
Simón-Vázquez, Rosana
Santander-Ortega, Manuel J
Serre, Christian
Author_xml – sequence: 1
  givenname: Elena
  surname: Bellido
  fullname: Bellido, Elena
  organization: Institut Lavoisier, UMR CNRS 8180, Université de Versailles Saint-Quentin-en-Yvelines, 45 Av. des Etats-Unis, 78035, Versailles cedex, France
– sequence: 2
  givenname: Tania
  surname: Hidalgo
  fullname: Hidalgo, Tania
  organization: Institut Lavoisier, UMR CNRS 8180, Université de Versailles Saint-Quentin-en-Yvelines, 45 Av. des Etats-Unis, 78035, Versailles cedex, France
– sequence: 3
  givenname: Maria Victoria
  surname: Lozano
  fullname: Lozano, Maria Victoria
  organization: Institut Lavoisier, UMR CNRS 8180, Université de Versailles Saint-Quentin-en-Yvelines, 45 Av. des Etats-Unis, 78035, Versailles cedex, France
– sequence: 4
  givenname: Mazheva
  surname: Guillevic
  fullname: Guillevic, Mazheva
  organization: Institut Lavoisier, UMR CNRS 8180, Université de Versailles Saint-Quentin-en-Yvelines, 45 Av. des Etats-Unis, 78035, Versailles cedex, France
– sequence: 5
  givenname: Rosana
  surname: Simón-Vázquez
  fullname: Simón-Vázquez, Rosana
  organization: Immunology, Biomedical Research Center (CINBIO) and Institute of Biomedical Research of Vigo (IBIV), Universidad de Vigo, Campus Lagoas Marcosende, 36310, Vigo, Pontevedra, Spain
– sequence: 6
  givenname: Manuel J
  surname: Santander-Ortega
  fullname: Santander-Ortega, Manuel J
  organization: Nanobiofar. Center for Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, Av. Barcelona s/n, Campus Vida, 15706, Santiago de Compostela, Spain
– sequence: 7
  givenname: África
  surname: González-Fernández
  fullname: González-Fernández, África
  organization: Immunology, Biomedical Research Center (CINBIO) and Institute of Biomedical Research of Vigo (IBIV), Universidad de Vigo, Campus Lagoas Marcosende, 36310, Vigo, Pontevedra, Spain
– sequence: 8
  givenname: Christian
  surname: Serre
  fullname: Serre, Christian
  organization: Institut Lavoisier, UMR CNRS 8180, Université de Versailles Saint-Quentin-en-Yvelines, 45 Av. des Etats-Unis, 78035, Versailles cedex, France
– sequence: 9
  givenname: Maria J
  surname: Alonso
  fullname: Alonso, Maria J
  organization: Nanobiofar. Center for Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, Av. Barcelona s/n, Campus Vida, 15706, Santiago de Compostela, Spain
– sequence: 10
  givenname: Patricia
  surname: Horcajada
  fullname: Horcajada, Patricia
  organization: Institut Lavoisier, UMR CNRS 8180, Université de Versailles Saint-Quentin-en-Yvelines, 45 Av. des Etats-Unis, 78035, Versailles cedex, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25771896$$D View this record in MEDLINE/PubMed
BookMark eNo1j01LAzEYhIMottZePUr-wNbkTZPd9SbFLyh40XPJJu-2qbvJ8mZL8d9b_JjLMPDMwFyx85giMnYjxUIKAXfW7_oFCLkUotT6jE1B1lCA0fWEzXPei5OMlqaSl2wCuixlVZsp27_gYCnEAuM2RERCz3vMaUiUDpkHSvGUR9sVibY2Bsdbsj0eE33yaGM6lcfgOsz3fExHS57nEW037rinw_YHcZYoIOVrdtHaLuP8z2fs4-nxffVSrN-eX1cP68Ity1IXvm5UDcbUlWmUkOBKAaAUoHQeNLaN8kIrrY31jZZKCAtgnGqtlrLFSsOM3f7uDoemR78ZKPSWvjb_p-EbwStb4A
CitedBy_id crossref_primary_10_1016_j_ccr_2019_04_006
crossref_primary_10_1039_C8TB03192D
crossref_primary_10_1049_bsb2_12012
crossref_primary_10_1039_C8RA03616K
crossref_primary_10_1021_acs_inorgchem_0c03550
crossref_primary_10_1016_j_ijpx_2023_100161
crossref_primary_10_3389_fbioe_2020_01027
crossref_primary_10_1016_j_cclet_2022_05_021
crossref_primary_10_1039_C7CC09739E
crossref_primary_10_1016_j_jece_2023_109967
crossref_primary_10_1080_16583655_2021_1996944
crossref_primary_10_1021_acs_molpharmaceut_8b01185
crossref_primary_10_1002_adhm_201900761
crossref_primary_10_1016_j_ijpharm_2021_121230
crossref_primary_10_3390_nano11030722
crossref_primary_10_1002_cmdc_201900596
crossref_primary_10_1016_j_aej_2023_11_086
crossref_primary_10_1021_acsinfecdis_3c00131
crossref_primary_10_1039_D3NR05776C
crossref_primary_10_1080_17425247_2022_2064450
crossref_primary_10_1016_j_nanoms_2021_12_003
crossref_primary_10_1039_C9NR08127E
crossref_primary_10_1021_acs_cgd_0c01090
crossref_primary_10_1021_acs_chemmater_3c01495
crossref_primary_10_1039_D3MD00416C
crossref_primary_10_1016_j_partic_2022_03_002
crossref_primary_10_1002_smll_202005064
crossref_primary_10_1016_j_reactfunctpolym_2024_105918
crossref_primary_10_1016_j_biomaterials_2018_06_007
crossref_primary_10_1016_j_ejpb_2018_08_013
crossref_primary_10_1039_C9RA06678K
crossref_primary_10_1021_acsami_0c20070
crossref_primary_10_1016_j_ijpharm_2020_119281
crossref_primary_10_1016_j_ijpharm_2022_121647
crossref_primary_10_2174_1573413719666230413084140
crossref_primary_10_1007_s10876_022_02348_w
crossref_primary_10_1016_j_ijpharm_2016_08_010
crossref_primary_10_1021_acsami_7b10064
crossref_primary_10_1016_j_addr_2022_114496
crossref_primary_10_1002_ente_202100212
crossref_primary_10_1016_j_biomaterials_2021_120951
crossref_primary_10_1039_C8TB00072G
crossref_primary_10_1016_j_colsurfa_2019_02_025
crossref_primary_10_1039_C9SC03802G
crossref_primary_10_1039_D3BM00758H
crossref_primary_10_1021_acsami_1c01089
crossref_primary_10_3390_jfb14060319
crossref_primary_10_1007_s40820_023_01180_9
crossref_primary_10_1002_adma_202005215
crossref_primary_10_1016_j_ccr_2018_09_009
crossref_primary_10_1016_j_envres_2023_115589
crossref_primary_10_1002_adfm_201909062
crossref_primary_10_1002_adma_201606134
crossref_primary_10_1002_smll_202206211
crossref_primary_10_1039_D3TB00027C
crossref_primary_10_1039_D3SC03659F
crossref_primary_10_1002_smll_201500802
crossref_primary_10_1002_cplu_202000496
crossref_primary_10_3390_ma14133652
crossref_primary_10_1039_D1CS00918D
crossref_primary_10_1016_j_ijbiomac_2023_127120
crossref_primary_10_1021_acsmaterialslett_2c01175
crossref_primary_10_1016_j_ccr_2015_08_008
crossref_primary_10_1016_j_ecoenv_2022_114275
crossref_primary_10_1016_j_chempr_2017_06_007
crossref_primary_10_1039_D3TB01819A
crossref_primary_10_1039_D2TB02094G
crossref_primary_10_1002_adtp_201800100
crossref_primary_10_3390_molecules25071598
crossref_primary_10_1016_j_biomaterials_2017_01_025
crossref_primary_10_3390_molecules25010185
crossref_primary_10_1021_acsnano_1c10942
crossref_primary_10_1021_acsami_2c05338
crossref_primary_10_1016_j_ccr_2020_213651
crossref_primary_10_1016_j_chempr_2023_09_016
crossref_primary_10_1039_C5TB01223F
crossref_primary_10_1016_j_ccr_2021_213949
crossref_primary_10_1021_acsami_7b17756
crossref_primary_10_1039_D1CS00468A
crossref_primary_10_1021_acs_energyfuels_1c00517
crossref_primary_10_1002_adfm_202312866
crossref_primary_10_3390_pharmaceutics12050437
crossref_primary_10_1021_acs_chemmater_6b00180
crossref_primary_10_1016_j_cclet_2019_11_036
crossref_primary_10_1039_C5TB02084K
crossref_primary_10_1002_asia_201801462
crossref_primary_10_1016_j_poly_2018_08_057
crossref_primary_10_1039_C6TB01652A
crossref_primary_10_1016_j_cclet_2022_107986
crossref_primary_10_1039_D2AY01230H
crossref_primary_10_1016_j_engreg_2020_06_001
crossref_primary_10_1021_acsami_8b09872
crossref_primary_10_1002_smtd_202201413
crossref_primary_10_3390_polym11101627
crossref_primary_10_1021_acs_molpharmaceut_8b00292
crossref_primary_10_1002_adfm_201606314
crossref_primary_10_1016_j_ccr_2019_02_032
crossref_primary_10_1002_jccs_202300115
crossref_primary_10_1021_acsami_9b21692
crossref_primary_10_1038_s43586_024_00320_8
crossref_primary_10_1016_j_biomaterials_2018_12_029
crossref_primary_10_1016_j_jddst_2020_102217
crossref_primary_10_1039_C9CE00757A
crossref_primary_10_1016_j_est_2022_105700
crossref_primary_10_1039_C6TB03101C
crossref_primary_10_1016_j_carbpol_2019_115085
crossref_primary_10_1016_j_cej_2023_144400
crossref_primary_10_1016_j_actbio_2018_05_050
crossref_primary_10_1002_asia_202000815
crossref_primary_10_1016_j_rechem_2024_101414
crossref_primary_10_1016_j_chemosphere_2021_130717
crossref_primary_10_1039_D1TB02339J
crossref_primary_10_1039_D3RA00930K
crossref_primary_10_1021_acsami_1c21555
crossref_primary_10_1039_D1TB00981H
crossref_primary_10_1021_acsami_0c21486
crossref_primary_10_1002_adfm_201908924
crossref_primary_10_1016_j_jddst_2022_103718
crossref_primary_10_3390_magnetochemistry6030039
crossref_primary_10_1039_D1SC04112F
crossref_primary_10_3390_app10155194
crossref_primary_10_1002_smll_201704440
crossref_primary_10_1021_acs_chemmater_2c01190
crossref_primary_10_1016_j_cej_2021_129386
crossref_primary_10_1002_smll_201801900
crossref_primary_10_1155_2018_9780489
crossref_primary_10_1515_zna_2021_0175
crossref_primary_10_1016_j_ccr_2021_214393
crossref_primary_10_1016_j_poly_2021_115509
crossref_primary_10_1039_C9DT04804A
crossref_primary_10_1002_adma_201707634
crossref_primary_10_1021_acs_biomac_9b00870
crossref_primary_10_1002_slct_202103519
crossref_primary_10_3390_pharmaceutics15051521
crossref_primary_10_1021_acsabm_3c00525
crossref_primary_10_1002_biot_202000005
crossref_primary_10_1021_acssuschemeng_8b05587
crossref_primary_10_1016_j_chemosphere_2022_134359
crossref_primary_10_1021_acs_cgd_2c01041
crossref_primary_10_1039_C7CS00041C
crossref_primary_10_1016_j_pmatsci_2019_100579
crossref_primary_10_1002_anie_201707346
crossref_primary_10_3390_pharmaceutics14020378
crossref_primary_10_1016_j_jconrel_2017_12_033
crossref_primary_10_2217_nnm_2023_0164
crossref_primary_10_1016_j_chempr_2017_02_005
crossref_primary_10_1039_C6TB02025A
crossref_primary_10_1002_smsc_202200044
crossref_primary_10_1016_j_ccr_2023_215335
crossref_primary_10_1007_s12274_020_3179_9
crossref_primary_10_1002_adma_201707365
crossref_primary_10_1016_j_ccr_2020_213212
crossref_primary_10_1021_acsnano_8b06287
crossref_primary_10_1016_j_tifs_2023_06_024
crossref_primary_10_1002_adhm_201600169
crossref_primary_10_1016_j_ccr_2018_08_010
crossref_primary_10_1007_s00216_019_02217_y
crossref_primary_10_1039_C7NR06777A
crossref_primary_10_1007_s11095_017_2253_9
crossref_primary_10_1016_j_cej_2019_123363
crossref_primary_10_1021_acsami_1c18055
crossref_primary_10_1021_acsbiomaterials_0c01600
crossref_primary_10_1016_j_ijbiomac_2023_124627
crossref_primary_10_1039_D0TB02804E
crossref_primary_10_1002_adhm_201600296
crossref_primary_10_1002_ange_201707346
crossref_primary_10_1038_srep43099
crossref_primary_10_1002_marc_201900333
crossref_primary_10_1021_acsami_1c01460
crossref_primary_10_3390_pharmaceutics13111945
ContentType Journal Article
Copyright 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Copyright_xml – notice: 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1002/adhm.201400755
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Engineering
EISSN 2192-2659
ExternalDocumentID 25771896
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 05W
0R~
1OC
33P
53G
8-0
8-1
A00
AAESR
AAHHS
AAIHA
AANLZ
AASGY
AAXRX
AAZKR
ABCUV
ABLJU
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACIWK
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AENEX
AEQDE
AEUYR
AFBPY
AFFPM
AFGKR
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMYDB
AZVAB
BDRZF
BFHJK
BMXJE
BRXPI
C45
CGR
CUY
CVF
D-A
D-B
DCZOG
DRFUL
DRMAN
DRSTM
EBD
EBS
ECM
EIF
EMOBN
G-S
HGLYW
HZ~
KBYEO
LATKE
LEEKS
LITHE
LOXES
LUTES
LYRES
MEWTI
MXFUL
MXMAN
MXSTM
MY.
MY~
NPM
O9-
OVD
P2W
PQQKQ
ROL
SUPJJ
SV3
TEORI
WBKPD
WOHZO
WXSBR
WYJ
ZZTAW
ID FETCH-LOGICAL-c4775-d9b39266986b3012c7022332e1cd25efb3d053556adb51300a226c3fa511fe852
IngestDate Sat Sep 28 08:06:14 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords heparin
porous
nanoparticles
cell uptake
metal-organic frameworks
Language English
License 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4775-d9b39266986b3012c7022332e1cd25efb3d053556adb51300a226c3fa511fe852
PMID 25771896
ParticipantIDs pubmed_primary_25771896
PublicationCentury 2000
PublicationDate June 3, 2015
PublicationDateYYYYMMDD 2015-06-03
PublicationDate_xml – month: 06
  year: 2015
  text: June 3, 2015
  day: 03
PublicationDecade 2010
PublicationPlace Germany
PublicationPlace_xml – name: Germany
PublicationTitle Advanced healthcare materials
PublicationTitleAlternate Adv Healthc Mater
PublicationYear 2015
SSID ssj0000651681
Score 2.5182111
Snippet The specific modification of the outer surface of the promising porous metal-organic framework nanocarriers (nanoMOFs) preserving their characteristic porosity...
SourceID pubmed
SourceType Index Database
StartPage 1246
SubjectTerms Animals
Cell Line, Tumor
Cell Survival
Chemical Phenomena
Coated Materials, Biocompatible - chemistry
Cytokines - metabolism
Delayed-Action Preparations
Drug Delivery Systems
Heparin - chemistry
Humans
Iron - chemistry
Leukocytes, Mononuclear - drug effects
Leukocytes, Mononuclear - metabolism
Metal Nanoparticles - chemistry
Mice
Porosity
Reactive Oxygen Species - metabolism
Title Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers
URI https://www.ncbi.nlm.nih.gov/pubmed/25771896
Volume 4
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLW68QIPiG8YA_mBt8qQuLGT8DZNgwrBnjq0t8mfa6ctnbaWh_6a_VTutZPUHUN8vESVnVZpzsn1sXN9LiHvijKrFShlZqusYoWGR7HOLGeOCwejh5Ze4dLAt0M5Piq-HIvjweAmyVpaLvR7s7pzX8n_oAptgCvukv0HZPsfhQb4DPjCERCG419hPHZYQ7BhrjUVBPF44a7nIKkxsRU3sGGFaHXOYu0mM_RdKtawUQ1Ml5OsuEXInx0i6LgvyV4tT8NJRl1hUbvrVMXudYkD03X2GCjf-Jf7CT5afdp5zB1zTR_-xzOrzk9D-wQuqm__Ol-pUAcc9w_N1PD7DN8nrPs_L3HbIgS2eMpq6n6odM0iFyG3KsYxF2IbxEnOuGzNwNtAXCR8q5KgChJE3hnto3usslO0FMixwnu0_E2gv7wI2ENggkG4ln_uveW-3XVtka2ywjh62K4GxZFe5LLKOy_QjH_YvBZ0mm6_f2vWEtTL5BF52E476F4E_DEZuOYJeZCYUT4lZ7-yia7ZRJFNdINNtGcT3WDTRxq5RFsuUeQSTbn0jBx9Opjsj1lbiYOZoiwFs7UGHS1lXUkNIwI3JUi_0Yi73Fh4qL0eWfQJElJZLfAFqQJVb0ZegZz3rhL8Odlu5o17SajS3HvjfK6sLGxZa5Hxsi4zbbThuravyIt4o04uo93KSXcLd37b85rcX7Nsl9zzQHb3BsTiQr8NiP0EuklwfA
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Heparin-engineered+mesoporous+iron+metal-organic+framework+nanoparticles%3A+toward+stealth+drug+nanocarriers&rft.jtitle=Advanced+healthcare+materials&rft.au=Bellido%2C+Elena&rft.au=Hidalgo%2C+Tania&rft.au=Lozano%2C+Maria+Victoria&rft.au=Guillevic%2C+Mazheva&rft.date=2015-06-03&rft.eissn=2192-2659&rft.volume=4&rft.issue=8&rft.spage=1246&rft_id=info:doi/10.1002%2Fadhm.201400755&rft_id=info%3Apmid%2F25771896&rft_id=info%3Apmid%2F25771896&rft.externalDocID=25771896